Remove Data Remove Media Remove Safety Remove Tincture
article thumbnail

cbdMD Therapeutics Releases Research Plan

Cannabis Law Report

The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. and are difficult to predict. cbdMD, Inc. John Weston. Director of Investor Relations.

article thumbnail

SICPA/HARRIS POLL CANNABIS LABELING SURVEY RESULTS

Cannabis Law Report

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans. The Harris Poll is one of the longest running surveys in the U.S. To learn more, please visit www.theharrispoll.com.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Publish Article “5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC”

Cannabis Law Report

The FDA is aware of media reports of delta-8 THC products getting consumers “high.” Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans. Findings based on NPDS data do not necessarily reflect the opinions of AAPCC. exposures to any substance(s). Read more at.

THC 105
article thumbnail

 Columbia Care Launches the UK’s Broadest Portfolio of Doseable Medical Cannabis Extract Vaporizer Pens; First Company to Manufacture Extract Vaporization Products in the UK

Cannabis Law Report

These new vaporizer pens complete Columbia Care’s initial medical product portfolio, which includes tinctures, launched in April 2020, and its proprietary solid-fill powder capsules, launched in April 2021, that remain unique in the UK market. Media Lindsay Wilson. media@col-care.com. Investor Lee Ann Evans. Investor Relations.

article thumbnail

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

Cannabis Law Report

1 We have also reviewed your social media websites at www.facebook.com/CuraleafHemp External Link Disclaimer and [link] External Link Disclaimer ; these websites direct consumers to your website, [link] External Link Disclaimer , to purchase your products. 355(a) and 331(d). Unapproved New and Misbranded Human Drug Products.

CBD 51
article thumbnail

Where Does The FDA Stand on CBD and CBD Products?

The Joint Blog

Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. FDA is the government agency that ensures the safety and quality of foods, drugs, cosmetics, and other like products marketed in the United States. CBD Legal and Safety Issues An FDA report presented to the U.S.

CBD 33
article thumbnail

Hemp wick vs butane lighter: What’s the best way to smoke weed?

SpeedWeed

Vapes, topicals, tinctures, sublinguals—more alternatives to smoking appear daily. Wurzer agreed, saying “I don’t have a ton of good data on this.”. For convenience and fire safety, flick that BIC. But die-hard tokers still wonder, what’s the best way to burn one? A trusty, old BIC, or the leading alternative, called hemp wick?

Hemp 52